At the TMA/The Deal's Distressed Investing Conference, Ed Weisfelner of Brown Rudnick Berlack Israels LLP spoke about how credit default swaps are affecting bankrupt Lyondell Chemical Co.'s restructuring. - Maria Woehr
Inside The Deal: Linklaters' Schmidt says how regulators handled Pfizer Inc.'s acquisition of Wyeth is an outlier of how others merger reviews will be conducted.
At the TMA/The Deal's Distressed Investing Conference, Ed Weisfelner of Brown Rudnick Berlack Israels LLP spoke about how credit default swaps are affecting bankrupt Lyondell Chemical Co.'s restructuring. - Maria Woehr
